JPMorgan lowered the firm’s price target on QuidelOrtho (QDEL) to $22 from $26 and keeps an Underweight rating on the shares. The firm views the company’s Q3 report as “noisy.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: